Dexlevo Introduces the World’s First Liquid-Type PCL at the AMWC, the World’s Largest Esthetic and Anti-Aging Congress
– Dexlevo, which marked a MOU with Hugel, went to the nineteenth Esthetic and Anti-maturing Medicine World Congress (AMWC, Esthetic Multispecialty Society) held in Monaco on September 16-18, 2021. The AMWC, one of the biggest worldwide stylish and hostile to maturing congresses, is a yearly occasion where more than 15,000 guests including clinical experts and industry members from in excess of 120 nations share the most recent clinical information.
Dexlevo prevailed with regards to melting polycaprolactone (PCL), a biodegradable polymer, interestingly, and fostered a clinical gadget for tissue rebuilding (fluid sort PCL injectable). Through this AMWC, Dexlevo advanced the greatness and provisions of the world’s first fluid sort PCL injectable to specialists from Europe and North America.
I would like to receive information from suppliers sponsoring this content and willing to share the information above with Business book25.SEND
Moreover, the organization held a satellite conference to advance the innovation and greatness of fluid kind PCL injectables. At the discussion, Dr. Arturo, a Mexican dermatologist, gave a talk (named “GOURI, completely solubilized PCL injectable for the collagenesis on the whole face”) about Dexlevo’s innovation, qualities, and separation as indicated by changes in the tasteful market pattern.
Dr. Chang-Shik Kim, a dermatologist, (Head of Chang Dermatology Clinic) gave a talk (named “Infusion Technique of GOURI, the completely solubilized PCL for the collagenesis on the whole face”) about the simplicity and component of the methodology with the fluid sort PCL injectable contrasted with contending items.
Mr. Chang-il Sohn, Vice President of Dexlevo, said, “We began examining contracts with enormous European organizations through having gatherings with 200 organizations at this AMWC, and could recognize the requirements for new items in the tasteful market.”
Dexlevo is relied upon to enter the European market vigorously, beginning with its presentation at the AMWC, and is intending to grow its market by proceeding to take an interest in the worldwide tasteful and against maturing displays later on.
As the more youthful age in their 20s and 30s, alongside the moderately aged and the old, are arising as significant buyers, the counter maturing market is developing quickly. The size of the worldwide tasteful market is assessed to arrive at KRW 12.7 trillion (USD 10.7 billion) by 2026 (source: DRG Research Data).
Set up in 2013, Dexlevo is a biodegradable polymer PCL-based tasteful clinical gadget maker. PCL has been utilized in the clinical field for quite a while, and its wellbeing for a human body has been demonstrated through FDA (US Food and Drug Administration) endorsements.
When infused into the skin of the face, the world’s first fluid sort PCL infusion normally spreads all through the whole face, for example, around the eyes, frames a three-dimensional network, and actuates collagen creation, in this way giving the impacts of restoring maturing skin.
In the interim, Dexlevo is talking about associations with worldwide drug organizations in Europe through getting CE confirmation in the European market, and clinical preliminaries are in progress determined to finish a KFDA (Korea Food and Drug Administration) endorsement by 2022.
